Cipla to buy two US generic drug firms for $550 million
Cipla Ltd said on Friday it has agreed to buy two generics businesses in the United States in an all-cash deals worth $550 million, as part of an effort to boost its presence in the world`s largest generics market.
Sep 04, 2015, 10:53 AM IST